Frequency of cross-resistance to rilpivirine and etravirine among HIV-1 subtype C infected individuals failing nevirapine/efavirenz based ART regimen
| Autor: | Rajesh Kannangai, Ben Chirag Ghale, Veena Vadhini Ramalingam, O C Abraham, John Paul Demosthenes, Priscilla Rupali, George Mannil Varghese |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Microbiology (medical) Efavirenz Nevirapine 030106 microbiology Human immunodeficiency virus (HIV) Etravirine medicine.disease_cause 03 medical and health sciences chemistry.chemical_compound Medicine Cross-resistance General Immunology and Microbiology Reverse-transcriptase inhibitor business.industry virus diseases General Medicine Virology humanities Regimen 030104 developmental biology Infectious Diseases chemistry Rilpivirine business medicine.drug |
| Zdroj: | Infectious Diseases. 51:71-74 |
| ISSN: | 2374-4243 2374-4235 |
| DOI: | 10.1080/23744235.2018.1510182 |
| Popis: | Sir,In a recent review of the present journal on antiretroviral treatment for HIV infection, the choice of non-nucleoside reverse transcriptase inhibitor (NNRTi) was discussed [1]. Based on availab... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|